---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-040381"
form_type: "8-K"
ticker: "XENE"
cik: "0001582313"
company_name: "Xenon Pharmaceuticals Inc."
filed_at: "2025-03-17T23:59:59+00:00"
generated_at: "2026-05-24T15:34:55.368975+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.0
calibrated_materiality_score: 0.0
confidence: "high"
source: SEC EDGAR
---

# Xenon Pharmaceuticals sets 2025 annual meeting for June 4, record date April 7

## Summary
- Annual meeting of shareholders scheduled for June 4, 2025.
- Record date for notice and voting is April 7, 2025.
- Common shares are the only securities entitled to vote.
- Issuer will use notice-and-access for both registered and non-registered investors.
- Issuer will pay for distribution of materials to objecting beneficial owners.

## SEC filing metadata
- accession: 0000950170-25-040381
- form_type: 8-K
- ticker: XENE
- cik: 0001582313
- company_name: Xenon Pharmaceuticals Inc.
- filed_at: 2025-03-17T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.0
- calibrated_materiality_score: 0.0
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1582313/000095017025040381/0000950170-25-040381-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1582313/000095017025040381/xene-20250314.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-040381
- JSON: https://secwatch.observer/filing/0000950170-25-040381.json
- Plain text: https://secwatch.observer/filing/0000950170-25-040381.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.